ASCO 2013 Video: Is nindetanib worthy of becoming a new treatment for NSCLC? - 1257544

1 post / 0 new
JimC
ASCO 2013 Video: Is nindetanib worthy of becoming a new treatment for NSCLC? - 1257544

GRACE videos from ASCO 2013 continue as Dr. Nate Pennell from Cleveland Clinic reviews the LUME Lung-1 trial presented by Reck at ASCO 2013, of Taxotere with or without nindetanib (BIBF-1120), an anti-angiogenic multikinase inhibitor, in advanced NSCLC.

You can view the video here: http://cancergrace.org/lung/2013/06/26/nindetanib-bibf1120-lume-lung-1/

We welcome your questions and comments here.

JimC
Forum moderator